Pulmonary hypertension associated with connective tissue disease

被引:62
作者
Fagan, KA [1 ]
Badesch, DB [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Pulm Hypertens Ctr, Denver, CO 80202 USA
关键词
D O I
10.1053/pcad.2002.129975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary arterial hypertension is a life threatening complication of several connective tissue diseases including scleroderma (both diffuse and limited scleroderma, or the CREST syndrome - calcinosis cutis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangectasia), systemic lupus erythomatosis (SLE), mixed connective tissue disease (MCTD), and less commonly, rheumatoid arthritis (RA) and dermatomyositis/polymyositis. This report reviews the occurrence of this complication, potential etiologies, clinical presentation, and treatment options. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:225 / 234
页数:10
相关论文
共 106 条
[1]  
Aguglia G, 2001, J RHEUMATOL, V28, P1563
[2]  
Allcock RJ, 2001, ARTHRITIS RHEUM, V44, P1660, DOI 10.1002/1529-0131(200107)44:7<1660::AID-ART289>3.0.CO
[3]  
2-W
[4]   ACUTE AND LONG-TERM EFFECTS OF NIFEDIPINE ON PULMONARY AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH PULMONARY-HYPERTENSION ASSOCIATED WITH DIFFUSE SYSTEMIC-SCLEROSIS, THE CREST SYNDROME AND MIXED CONNECTIVE-TISSUE DISEASE [J].
ALPERT, MA ;
PRESSLY, TA ;
MUKERJI, V ;
LAMBERT, CR ;
MUKERJI, B ;
PANAYIOTOU, H ;
SHARP, GC .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (17) :1687-1691
[5]   SHORT-TERM AND LONG-TERM HEMODYNAMIC-EFFECTS OF CAPTOPRIL IN PATIENTS WITH PULMONARY-HYPERTENSION AND SELECTED CONNECTIVE-TISSUE DISEASE [J].
ALPERT, MA ;
PRESSLY, TA ;
MUKERJI, V ;
LAMBERT, CR ;
MUKERJI, B .
CHEST, 1992, 102 (05) :1407-1412
[6]  
ALSABBAGH MR, 1989, J RHEUMATOL, V16, P1038
[7]   PULMONARY MANIFESTATIONS OF SCLERODERMA [J].
ARROLIGA, AC ;
PODELL, DN ;
MATTHAY, RA .
JOURNAL OF THORACIC IMAGING, 1992, 7 (02) :30-45
[8]  
ASHERSON RA, 1990, J RHEUMATOL, V17, P1292
[9]  
ASHERSON RA, 1986, J RHEUMATOL, V13, P1
[10]   Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].
Badesch, DB ;
Tapson, VF ;
McGoon, MD ;
Brundage, BH ;
Rubin, LJ ;
Wigley, FM ;
Rich, S ;
Barst, RJ ;
Barrett, PS ;
Kral, KM ;
Jöbsis, MM ;
Loyd, JE ;
Murali, S ;
Frost, A ;
Girgis, R ;
Bourge, RC ;
Ralph, DD ;
Elliott, CG ;
Hill, NS ;
Langleben, D ;
Schilz, RJ ;
McLaughlin, VV ;
Robbins, IM ;
Groves, BM ;
Shapiro, S ;
Medsger, TA ;
Gaine, SP ;
Horn, E ;
Decker, JC ;
Knobil, K .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+